Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein

T Stürmer, H Brenner, W Koenig, K-P Günther, T Stürmer, H Brenner, W Koenig, K-P Günther

Abstract

Background: Although osteoarthritis (OA) is thought to derive from defective chondrocyte metabolism and thus inherently lack the large scale systemic response of rheumatoid arthritis, there is increasing interest in the acute phase proteins in OA.

Objective: To assess the association between high sensitivity C reactive protein (hsCRP) and severity and extent of OA in patients with advanced hip and knee OA.

Methods: Preoperative hsCRP was measured in frozen serum samples from 770 consecutive patients with hip or knee joint replacement due to advanced OA recruited between 1995 and 1996. Pain was measured by a visual analogue scale and the Western Ontario and McMaster Universities OA index (WOMAC). The extent of OA in different joints was assessed clinically and radiographically.

Results: The (geometric) mean hsCRP was 2.5 mg/l among all patients. Severity of pain was associated with mean hsCRP (adjusted elevation highest v lowest quintile = 35%, p = 0.01) after controlling for known or suspected predictors of hsCRP, including age, smoking, and body mass index. Neither the bilateral nor the generalised extent of OA, nor any of the dimensions of the WOMAC were associated with mean hsCRP levels.

Conclusions: Severity of pain, but not extent of OA, was associated with hsCRP levels in this group of patients with advanced OA. Longitudinal studies with repeated assessments of hsCRP and pain are needed to assess the possible value of hsCRP for monitoring or predicting the clinical course of OA.

References

    1. Pain. 1999 Aug;Suppl 6:S141-7
    1. Am J Med. 2001 Nov;111(7):521-7
    1. Clin Exp Rheumatol. 2000 Mar-Apr;18(2 Suppl 19):S33-8
    1. Ann Rheum Dis. 2000 Apr;59(4):289-92
    1. Am J Epidemiol. 1999 Nov 15;150(10):1117-27
    1. Clin Rheumatol. 1999;18(5):402-5
    1. J Rheumatol. 1999 Aug;26(8):1785-92
    1. Amyloid. 1999 Jun;6(2):130-5
    1. Rheumatology (Oxford). 1999 Apr;38(4):355-61
    1. Surg Clin North Am. 1999 Apr;79(2):231-52
    1. Ann Rheum Dis. 1998 Dec;57(12):717-23
    1. Rev Rhum Engl Ed. 1998 Dec;65(12):759-65
    1. Z Orthop Ihre Grenzgeb. 1997 May-Jun;135(3):197-202
    1. Z Orthop Ihre Grenzgeb. 1997 May-Jun;135(3):184-92
    1. J Rheumatol. 1997 Aug;24(8):1486-8
    1. Br J Rheumatol. 1997 Jul;36(7):726-8
    1. Z Orthop Ihre Grenzgeb. 1997 Jan-Feb;135(1):3-8
    1. Arthritis Rheum. 1997 Apr;40(4):723-7
    1. Br J Rheumatol. 1997 Jan;36(1):140-1
    1. Osteoarthritis Cartilage. 1995 Sep;3 Suppl A:3-70
    1. Prog Clin Biol Res. 1987;227B:271-9
    1. Arthritis Rheum. 1988 Mar;31(3):315-24
    1. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):51-6
    1. Semin Arthritis Rheum. 1989 May;18(4 Suppl 2):81-5
    1. J Rheumatol. 1992 Jan;19(1):153-9
    1. Ann Rheum Dis. 1957 Dec;16(4):494-502
    1. Diabetes Care. 2000 Dec;23(12):1835-9
    1. Clin Chem. 2001 Mar;47(3):426-30
    1. Lancet. 2001 Mar 10;357(9258):763-7
    1. Circulation. 2001 Apr 3;103(13):1813-8
    1. Br J Anaesth. 2001 Jul;87(1):3-11

Source: PubMed

3
Abonner